124 related articles for article (PubMed ID: 20860031)
1. Regulation of the 5-HT3A receptor-mediated current by alkyl 4-hydroxybenzoates isolated from the seeds of Nelumbo nucifera.
Youn UJ; Lee JH; Lee YJ; Nam JW; Bae H; Seo EK
Chem Biodivers; 2010 Sep; 7(9):2296-302. PubMed ID: 20860031
[TBL] [Abstract][Full Text] [Related]
2. Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Choi S; Lee JH; Oh S; Rhim H; Lee SM; Nah SY
Mol Cells; 2003 Feb; 15(1):108-13. PubMed ID: 12661769
[TBL] [Abstract][Full Text] [Related]
3. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
4. Effects of protostane-type triterpenoids on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Kang SW; Kim Y; Shin M; Hong M; Seo EK; Kim SH; Nah SY; Bae H
Brain Res; 2010 May; 1331():20-7. PubMed ID: 20307506
[TBL] [Abstract][Full Text] [Related]
5. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
6. Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT
Alix K; Khatri S; Mosier PD; Casterlow S; Yan D; Nyce HL; White MM; Schulte MK; Dukat M
ACS Chem Neurosci; 2016 Nov; 7(11):1565-1574. PubMed ID: 27533595
[TBL] [Abstract][Full Text] [Related]
7. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
8. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in 5-HT3 receptor pharmacology.
Thompson AJ
Trends Pharmacol Sci; 2013 Feb; 34(2):100-9. PubMed ID: 23380247
[TBL] [Abstract][Full Text] [Related]
10. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of ginsenoside metabolites on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Lee BH; Jeong SM; Lee JH; Kim DH; Kim JH; Kim JI; Shin HC; Lee SM; Nah SY
Mol Cells; 2004 Feb; 17(1):51-6. PubMed ID: 15055527
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I.
Lee BH; Jeong SM; Lee JH; Kim JH; Yoon IS; Lee JH; Choi SH; Lee SM; Chang CG; Kim HC; Han Y; Paik HD; Kim Y; Nah SY
Mol Cells; 2005 Aug; 20(1):69-73. PubMed ID: 16258243
[TBL] [Abstract][Full Text] [Related]
13. Direct modification of the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Eur J Pharmacol; 2018 Feb; 821():21-28. PubMed ID: 29277715
[TBL] [Abstract][Full Text] [Related]
14. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
15. Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Shin JK; Nam JW; Nah SY; Kim SH; Jeong JH; Kim Y; Shin M; Hong M; Seo EK; Bae H
Eur J Pharmacol; 2009 Aug; 615(1-3):27-32. PubMed ID: 19446542
[TBL] [Abstract][Full Text] [Related]
16. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
17. Yokukansan contains compounds that antagonize the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Phytomedicine; 2018 Apr; 43():120-125. PubMed ID: 29747744
[TBL] [Abstract][Full Text] [Related]
18. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
Koo BN; Kim MK; Yang J; Min KT
Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
[TBL] [Abstract][Full Text] [Related]
19. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
